Matching
Indicate whether each of the following statements is True or False.
Premises:
A possible side-effect of using antilymphocyte globulin (ALG) is serum sickness.
Immunosuppressive xenogeneic antibodies can be used repeatedly for multiple episodes of transplant rejection without complication.
Daclizumab, an anti-CD3 humanized antibody, is used to treat and prevent acute rejection.
Antithymocyte globulin (ATG) is a monoclonal antibody specific for T-cell surface antigens
Dosage of immunosuppressive drugs is often decreased in transplant patients to minimize toxic side-effects, but there is a risk of rejection.
Responses:
False
True
Correct Answer:
Premises:
Responses:
A possible side-effect of using antilymphocyte globulin (ALG) is serum sickness.
Immunosuppressive xenogeneic antibodies can be used repeatedly for multiple episodes of transplant rejection without complication.
Daclizumab, an anti-CD3 humanized antibody, is used to treat and prevent acute rejection.
Antithymocyte globulin (ATG) is a monoclonal antibody specific for T-cell surface antigens
Dosage of immunosuppressive drugs is often decreased in transplant patients to minimize toxic side-effects, but there is a risk of rejection.
Premises:
A possible side-effect of using antilymphocyte globulin (ALG) is serum sickness.
Immunosuppressive xenogeneic antibodies can be used repeatedly for multiple episodes of transplant rejection without complication.
Daclizumab, an anti-CD3 humanized antibody, is used to treat and prevent acute rejection.
Antithymocyte globulin (ATG) is a monoclonal antibody specific for T-cell surface antigens
Dosage of immunosuppressive drugs is often decreased in transplant patients to minimize toxic side-effects, but there is a risk of rejection.
Responses:
Related Questions
Q41: _ is a nitrogen mustard compound converted
Q42: _ from a bone marrow transplant facilitate
Q43: _ is/are a disease or genetic defect
Q44: Corticosteroids interfere with chemotaxis of leukocytes by
Q45: Residual leukemia cells persisting in a patient
Q47: A.Are the criteria for selecting suitable donors
Q48: When an individual receives a kidney transplant,the
Q49: _ describes the process by which transplanted
Q50: The term _ is used to describe
Q51: Autologous bone marrow transplantation used to treat